Millennium Management
ACET icon

Millennium Management’s Adicet Bio ACET Stock Holding History

Millennium Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,206
Closed -$602K – 6292
2022
Q4 		$602K Buy
+4,206
New +$1.05M ﹤0.01% 4597
2022
Q3 		– Sell
-3,125
Closed -$730K – 7010
2022
Q2 		$730K Hold
3,125
– – ﹤0.01% 4659
2022
Q1 		$999K Buy
+3,125
New +$719K ﹤0.01% 4517

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Millennium Management's ACET Position: Q4 2025 in Review

Millennium Management sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 35,372 shares — an estimated $459K sold.

Millennium Management first reported a position in ACET in Q3 2018 and held it in 21 quarters. The position peaked at $9.65M in Q1 2024. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Millennium Management reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Millennium Management sold 35,372 Adicet Bio shares in Q4 2025, an estimated $459K.
  • Millennium Management first reported a position in Adicet Bio in Q3 2018 and held it in 21 quarters.
  • Millennium Management's Adicet Bio position peaked at $9.65M in Q1 2024.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.